Healthspan Capital is a venture capital firm with a mission to broadly invest and support longevity biotechnology ("LongBio") companies developing therapeutics to extend healthy human lifespan. We believe that rejuvenation biotechnology is the future of medicine.
Healthspan Capital was founded in 2021 by Sebastian Brunemeier, Nathan Cheng, and Michael Chinen.
We invest in early stage longevity biotech ("LongBio") -- meaning companies that are developing therapeutics that target aging. We invest in pre-Seed to Series A companies.
People
- Sebastian Brunemeier, Co-Founder & Partner
You last contacted this investor on .